World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website https://wjon.elmerpub.com

Original Article

Volume 17, Number 3, June 2026, pages 357-365


Exploring Two Decades of Cancer Trends in Adolescents and Young Adults: Insights From a Resource-Restricted Country

Figures

↓  Figure 1. Most common cancers among AYA patients (%), year 2000–2022. (a) Distribution of the most common cancers reported across the entire AYA population. (b) Most common cancers among female AYA patients. (c) Most common cancers among male AYA patients. AYA: adolescent and young adult; CNS: central nervous system; HD: Hodgkin lymphoma; NHL: non-Hodgkin lymphoma.
Figure 1.
↓  Figure 2. Trends in AYA cancer incidence across age group categories (number). AYA: adolescent and young adult.
Figure 2.
↓  Figure 3. Age-standardized incidence rate (ASIR) of AYA cancers by age group (per 100,000 population), year 2000–2022. AYA: adolescent and young adult.
Figure 3.
↓  Figure 4. Overall survival of AYA cancer patients by age group category, year 2000–2022. AYA: adolescent and young adult.
Figure 4.

Table

↓  Table 1. Challenges in AYA Cancer Management
 
Key issuesClinical and supportive needsBarriers and challenges
AYA: adolescent and young adult.
Availability of early detection and screening tools (when indicated)Need for advanced imaging and screening modalities beyond routine recommendations (e.g., breast MRI instead of mammogram).Financial burden/high cost; limited convenience; restricted access
More aggressive disease compared to older patientsRequires intensified treatment approaches, including chemotherapy and immunotherapy (e.g., higher prevalence of triple-negative breast cancer).Financial burden/high cost; delayed adverse events; limited access and availability of new drugs
Higher prevalence of pathogenic/likely pathogenic (P/LP) germline mutationsNeed for standardized, simplified genetic testing guidelines across all tumor types.Financial burden/high cost; family communication challenges and the complexity of cascade testing; risk of stigmatization
Fertility preservationMany chemotherapeutic agents may impair fertility. Oocyte preservation and sperm banking should be addressed with patients after proper counseling.
The process can be particularly challenging for younger patients.
Financial burden/high cost; limited access to fertility preservation services; procedural difficulty, especially for younger patients
Body image concernsNeed for access to reconstructive and plastic surgery (e.g., mastectomy reconstruction). Psychological impact on body image.High cost of procedures; limited availability of specialized surgical services